- HCC-78
- HDLM-2
- DOHH-2
- L-540
- MX-1
- NALM-6
- NB-4
- CAL-51
- SNB-19
- KYSE-520
- MKN-45
- BA/F3
- MS-5
- HCEC-B4G12
- NK-92
- PA-TU-8988S
- MONO-MAC-1
- PA-TU-8902
- Human Microglia
- Human Hepatic Stellate Cells
- Human Skeletal Muscle Cells (DMD)
- Human Schwann Cells
- Human Oral Keratinocytes (HOK)
- Human Cardiomyocytes
- Human Small Intestinal Epithelial Cells
- Human Colonic Epithelial Cells
- Human Intestinal Fibroblasts
- Primary Human Large Intestine Microvascular Endothelial Cells
- Human Small Intestinal Microvascular Endothelial Cells
- Human Retinal Pigment Epithelial Cells
- Human Hepatocytes
- Cynomolgus Monkey Lung Microvascular Endothelial Cells
- Cynomolgus Monkey Vein Endothelial Cells
- C57BL/6 Mouse Primary Mammary Epithelial Cells
- C57BL/6 Mouse Vein Endothelial Cells
- Rat Primary Kidney Epithelial Cells
- Rat Gingival Epithelial Cells
- Rabbit Lung Endothelial Cells
Our Promise to You
Guaranteed product quality, expert customer support
ONLINE INQUIRY
Human Umbilical Vein Smooth Muscle Cells (HUVSMC)
Cat.No.: CSC-7698W
Species: Human
Source: Umbilical Cord; Vein
Cell Type: Smooth Muscle
- Specification
- Q & A
- Customer Review
Ask a Question
Write your own review
Description: CD34 is a well-known cell surface marker for primitive and bone marrow-derived progenitor cells, especially for hematopoietic and endothelial progenitors. Within cord blood, there are CD34+ and another population that is both CD34+/CD133+. Creative Bioarray provides CD34+/CD133+ progenitor cells in a phenotypically undifferentiated state. The progenitor cells are derived from cord blood of consented healthy donors and each vial contains at least 1*10^5 cells.
Description: HUASMC from Creative Bioarray are isolated from human umbilical arteries. HUASMC are cryopreserved at the end of secondary culture and delivered frozen. Each vial contains >5 x 10^5 cells in 1 ml volume. HUASMC are characterized by immunofluorescent method with antibodies to ?-smooth muscle actin and desmin. HUASMC are negative for HIV-1, HBV, HCV, mycoplasma, bacteria, yeast and fungi. HUASMC are guaranteed to further expand for 15 population doublings at the condition provided by Creative Bioarray.
Description: Human umbilical cord blood mononuclear cells are isolated from umbilical cord blood. Human umbilical cord blood mononuclear cells are from a single donor. These cells contain CD34+ stem cells. They enable researchers to produce various cell types of the hematopoietic lineage using standard published protocols. These cells may be used for various studies on hematopoiesis, differentiation, angiogenesis, colony formation, and surface marker expression. Presently, they are widely investigated for various therapeutic applications.
Development period: Post Natal
Description: Human Cord Blood Mononuclear Cells from Creative Bioarray are isolated from normal cord blood. The Mononuclear Cells are cryopreserved Immediately after isolation.Each cryo vial contains more than 25 million viable cells after thawing.
Description: Human CD34+ umbilical cord blood cells are isolated from umbilical cord blood and purified using magnetic cell separation. Human CD34+ umbilical cord blood cells are from a single donor and are >90% pure populations as confirmed by FACS analysis. These cells are regularly used to reconstitute the hematopoietic system in infants and small children with malignancies. These cells also enable researchers to produce various cell types using standard published protocols. Additionally, CD34+ umbilical cord blood cells may be used for various studies on hematopoiesis, differentiation, angiogenesis, colony formation, and surface marker expression. Presently, they are widely investigated for various therapeutic applications.
Development period: Postnatal
Description: Human CD34+ umbilical cord blood cells are isolated from umbilical cord blood and purified using magnetic cell separation. Human CD34+ umbilical cord blood cells are >90% pure populations as confirmed by FACS analysis. These cells are regularly used to reconstitute the hematopoietic system in infants and small children with malignancies. These cells also enable researchers to produce various cell types using standard published protocols. Additionally, CD34+ umbilical cord blood cells may be used for various studies on hematopoiesis, differentiation, angiogenesis, colony formation, and surface marker expression. Presently, they are widely investigated for various therapeutic applications.
Development period: Postnatal
